Credits: Canva
Quademic 2025: Hospitals in the United States are dealing with a surge in patients admission, the reason is the quademic it is dealing with at this moment. This has led to an influx of patients. It is all caused by seasonal infections, including common flu, Covid-19, and respiratory syncytial virus (RSV) that dominate the winter season in the US. This year, norovirus also joined the list, which has further increased the load on the healthcare.
The healthcare company founded in academics M Health Fairview, confirmed that their hospitals are overflowing due to the quademic.
The hospitals of M Health Fairview's volume is up by 30% and as a results, patients are being treated in the hallways and in alternative care areas. There is also a longer wait time and shortages for resources that are required to treat these emergencies. This has also impacted other life-threatening emergencies like heart attacks and strokes, as the healthcare resources and caregivers are occupied with the surge in seasonal cases.
ALSO READ: Birmingham Struggles With 4 Different Virus Hits, Know What They Are
Common cold and flu: The common cold and influenza (flu) are perhaps the most well-known illnesses that peak during the fall. As temperatures drop and humidity levels fluctuate, viruses that cause colds and the flu become more active. The flu, in particular, can be more severe than a common cold, leading to complications such as pneumonia, especially in vulnerable populations like the elderly and those with pre-existing health conditions. Symptoms include a runny nose, sore throat, coughing, fever, and body aches.
Covid-19: As per the World Health Organization, Coronavirus disease or COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with this virus will experience mild to moderate respiratory illness and recover without requiring special treatment, However, there could be some cases of seriously ill patients who may require medical attention. It is also because of the other existing medical conditions like cardiovascular diseases, diabetes, chronic respiratory diseases, cancers, or older age.
The best way to protect against this virus is by following social isolation form those who are infected, using mask to prevent droplets from infecting others when you cough or sneeze and to wash your hands for 20 seconds frequently.
RSV or Respiratory Syncytial Virus: As per the Centers of Diseases Control and Prevention (CDC), RSV is a common respiratory virus that infects nose, throat and lungs. Though symptoms are similar to the viruses like flu or COVID-19, the disease in itself is different. It also peaks during the winter season, especially between December and January.
However, the main difference between RSV and other respiratory illness, above mentioned is that RSV can cause pneumonia or bronchiolitis, especially for those who are over the age of 50 or with an existing heart or lung disease.
Norovirus: It is a number 1 cause of foodborne illness in the US and this happens when virus gets into the food and then it accidentally enters your mouth. These particles are from faeces or vomit from infected people, or can be transmitted via contaminated food and water. It could also spread by touching unclean surfaces like door handles or cutlery.
For most people, having norovirus is unpleasant, but mild and recovery could be made in 1 to 2 days. However, it could be more serious for babies, older people and anyone with any existing health condition.
Credit: AI
The US Department of Health and Human Services (HHS) has decertified Network for Hope, the federally funded organ procurement organization (OPO), which serves Kentucky and parts of Ohio, and West Virginia.
HHS officials cited "persistent safety failures" that could undermine public trust in organ transplantation as the reason for their move.
The move comes after months-long federal investigation into cases where organ recovery procedures were initiated despite patients showing signs of life.
The announcement marks one of the most significant federal actions against an organ procurement organization in recent years. It comes amid a bigger overhaul of the US organ transplant system.
"We're taking action because one bad apple can undermine trust in the entire transplant system," US Health Secretary Robert F. Kennedy Jr. said while announcing the proposed decertification, adding that patient safety and trust must remain the highest priority.
The investigation stems from a widely reported 2021 case involving a Kentucky man who was being evaluated for organ donation after a drug overdose.
According to federal officials, preparations for organ retrieval continued even though the patient reportedly began showing neurological signs suggesting he was regaining consciousness. The procedure was ultimately halted, and the man survived.
Following that incident, the Health Resources and Services Administration (HRSA) reviewed 351 cases in which organ donation had been authorized but not completed.
Also read: Dr. Erica Schwartz Confirmed As CDC’s First Permanent Director In Nearly A Year
Federal investigators found:
Investigators also pointed out ineffective neurological examinations, inadequate coordination between hospitals and procurement teams, questionable consent practices, and inconsistencies and errors in determining causes of death, particularly in cases of deaths due to overdose.
Network for Hope has rejected the allegations and said it plans to appeal the proposed decertification.
In a statement, the organization said it "strongly disagrees" with the decision and maintains that it follows federal policies governing organ donation.
It also said that it has already introduced additional safeguards and strict policies, including instructing staff to stop organ donation procedures if ethical and legal concerns arise.
Most importantly, OPOs have no authority to declare death. That decision is made independently by hospital physicians before any organ recovery process can begin.
Most organ donations occur after brain death or circulatory death under strict medical protocols.
Earlier investigations into the Kentucky cases caused led to removing themselves from organ donor registries, raising concerns that safety controversies could reduce the availability of organs for patients awaiting transplantation.
Currently, more than 100,000 Americans are currently waiting for a life-saving organ transplant, with kidneys accounting for the majority of the demand. While organ donation remains one of the most effective ways to save lives, public confidence is essential to keeping donor registrations high.
Credit: AI
The U.S. Senate has confirmed Dr. Erica Schwartz as the next Director of the U.S. Centers for Disease Control and Prevention (CDC), making her the public health agency's first permanent leader in nearly a year after months of uncertainty. The Senate approved her nomination in a 51-44 vote on August 5.
President Donald Trump nominated Schwartz in April, calling her "incredibly talented." During her confirmation hearing, she pledged to lead the CDC with transparency and scientific integrity.
She succeeds acting CDC Director Dr. Jay Bhattacharya, who had been leading the agency since February.
"I will lead with transparency, scientific integrity and accountability," Schwartz told senators during her confirmation hearing.
Schwartz, a physician, lawyer and former U.S. Deputy Surgeon General has an extensive background in medicine.
She takes charge of the CDC at a time when it is battling multiple outbreaks, staff shortages and growing scrutiny and uncertainty over its scientific independence.
The agency has also undergone major workforce reductions while responding to several public health challenges, including a resurgence of measles, foodborne illness outbreaks and international infectious disease threats.
Schwartz's appointment is expected to bring stability to an agency that plays a central role in tracking disease outbreaks, issuing vaccination recommendations, responding to health emergencies and guiding public health policy in the US.
Also read: US Measles Cases Reach 2,371; RFK Jr Takes U-Turn, Urges Families to Vaccinate Kids
Schwartz obtained her medical degree from Brown University and also holds a Master of Public Health and a law degree. She served in the U.S. Navy before joining the U.S. Public Health Service, where she later became Deputy Surgeon General during President Trump's first administration.
She has also served as Chief Medical Officer of the U.S. Coast Guard and most recently held leadership positions in the private healthcare sector.
Her confirmation comes as public health experts closely watch how the CDC balances scientific decision-making with increasing political scrutiny.
Many believe her appointment will be critical in rebuilding confidence in one of the world's most influential public health agencies.
Also read: One In Three Hospital Patients With Serious Mould Infections Died, CDC Study Finds
Dr. Erica Schwartz is President Donald Trump's third CDC nominee in less than two years.
Schwartz ha pledged to restore public trust in the CDC through transparency and evidence-based decision-making during her confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions (HELP).
Throughout her nomination hearing, Schwartz repeatedly expressed support for vaccines, including mRNA COVID-19 vaccines, and strongly endorsed vitamin K injections for newborns to prevent life-threatening bleeding.
Although she also acknowledged that scientific evidence does not support that vaccines cause autism, she argued that more research is needed to better understand the rising cases of autism.
"We owe it to the American people to figure out why one in 30 children now has autism," she said.
Schwartz stated that she did not believe either President Trump or Health Secretary Kennedy would ask her to take actions that would harm public health or violate the law.
Credit: iStock
Amid rising global infertility rates, a new study has found that an imbalance in the bacteria present in men's semen may reduce a couple's chances of having a baby and increase the risk of pregnancy loss. Researchers also found that the composition of women's gut bacteria may influence fertility outcomes.
The study, published in The Lancet Obstetrics, Gynaecology & Women's Health, found these associations were particularly evident among couples undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), as well as those with a history of recurrent pregnancy loss.
Researchers from the University of Copenhagen, Denmark, said the findings point to "imbalances in men's semen and in women's gut bacteria as previously overlooked and potentially treatable risk factors for infertility and recurrent pregnancy loss."
Although the vaginal microbiome has been studied extensively in relation to fertility, the gut and seminal microbiomes have been largely overlooked.
“Incorporation of couple-level microbial assessment might represent a novel approach for targeted therapeutic strategies,” the team said.
The researchers followed 353 women and 191 of their male partners between April 2018 and September 2023. All participants were heterosexual couples undergoing fertility treatment or had experienced recurrent pregnancy loss.
They analyzed bacterial communities in the women's gut and vagina and in the men's semen before tracking pregnancies and birth outcomes. About one in four men had an unhealthy bacterial imbalance, known as dysbiosis, in their semen.
Among couples undergoing IVF or ICSI:
The researchers also noted that standard semen analysis cannot detect this bacterial imbalance, meaning a man's test results may appear normal even when dysbiosis is present.
The study found that an imbalance in women's gut bacteria was associated with:
However, gut bacterial imbalance was not associated with miscarriage, while an imbalance in vaginal bacteria showed no clear link with either infertility or pregnancy loss.
According to the researchers, assessing the microbiome in both men and women could improve infertility evaluation and help identify previously overlooked, potentially treatable factors affecting fertility.
They added that, if confirmed in larger studies, therapies aimed at restoring healthy bacterial balance in semen and the gut could improve fertility outcomes and reduce recurrent pregnancy loss.
Infertility is a disease of the male or female reproductive system, defined as the inability to achieve pregnancy after 12 months or more of regular, unprotected sexual intercourse.
According to the World Health Organization (WHO), one in six people globally experience infertility during their lifetime. The condition can cause significant emotional distress, social stigma and financial hardship, with far-reaching effects on mental and psychosocial well-being.
© 2024 Bennett, Coleman & Company Limited